This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Innovations of Theo Van der Knaap: Pioneering Processes in Chemical Development
Introduction
Theo Van der Knaap, an inventive mind based in Grevenbicht, Netherlands, has made significant contributions to the field of chemical innovations. With a total of two patents to his name, Van der Knaap continues to develop processes that enhance the production of valuable chemical compounds. His work is primarily associated with Bayer Aktiengesellschaft, a leading global enterprise in the life sciences sector.
Latest Patents
Theo Van der Knaap's latest innovations focus on a remarkable process for the production of 1-amino-1-methyl-3(4)-aminomethylcyclohexane. Furthermore, he has also patented a method specifically for the preparation of the same compound, 1-amino-1-methyl-3(4)-aminomethyl cyclohexane (AMCA). These patents represent significant advancements in the synthesis of complex chemicals used in various applications.
Career Highlights
Throughout his career, Theo has demonstrated commitment to advancing chemical processes that improve efficiency and effectiveness in production. His association with Bayer Aktiengesellschaft has provided him with the platform to innovate and collaborate with other talented professionals in the industry.
Collaborations
In the course of his career, Theo Van der Knaap has worked closely with notable colleagues such as Konrad Fischer and Oswald Wilmes. These collaborations have undoubtedly enriched his work and contributed to the successful development of his patents.
Conclusion
Theo Van der Knaap exemplifies the role of inventors in driving progress within the chemical industry. His innovative approaches to chemical production, particularly in the development of 1-amino-1-methyl-3(4)-aminomethylcyclohexane, highlight the importance of continuous research and collaboration in achieving significant advancements. The contributions of Van der Knaap and his colleagues at Bayer demonstrate the potential of innovation to shape future developments in science and industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile